📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The Cannabinoid-Like Compound, VSN16R, Acts on Large Conductance, Ca2+-Activated K+ Channels to Modulate Hippocampal CA1 Pyramidal Neuron Firing. (2019)

First Author: Tabatabaee S

Attributed to: Biomedical Catalyst – Drug product production, clinical support studies, and phase 1 trial of a new MS drug funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3390/ph12030104

PubMed Identifier: 31277369

Publication URI: http://europepmc.org/abstract/MED/31277369

Type: Journal Article/Review

Volume: 12

Parent Publication: Pharmaceuticals (Basel, Switzerland)

Issue: 3

ISSN: 1424-8247